BBK Worldwide® Blog

BBK’s Take: Draft Bill to Accelerate 21st Century Cures

Posted by Bonnie A. Brescia on Thu, Apr 30, 2015

During the first 25 years of the Orphan Drug Act (passed in 1983), only 326 new drugs were approved by the FDA and brought to market for all rare disease patients combined. Prior to the Orphan Drug Act, fewer than 10 treatments had been developed by industry for rare diseases. This is progress however; there is a lot of work to be done.

Read More

Topics: Patient Centricity, 21st Century Cures